This Is MS Multiple Sclerosis Community: Knowledge & Support

Welcome to the world's leading forum on Multiple Sclerosis research, support, and knowledge. For over 10 years, This is MS has provided an unbiased community dedicated to Multiple Sclerosis patients, caregivers, and affected loved ones.
It is currently Wed Jun 19, 2013 10:30 pm


All times are UTC - 8 hours [ DST ]




Post new topic Reply to topic  [ 4 posts ] 
Author Message
PostPosted: Thu Nov 01, 2012 2:27 am 
Offline
Family Elder
User avatar

Joined: Wed Oct 14, 2009 3:00 pm
Posts: 1711
Alemtuzumab lessens relapses, improves disability in MS - studies

Image

Two new trials offer proof that a leukemia drug long used to treat multiple sclerosis works better than a common treatment.

When compared with the widely used drug interferon beta, the leukemia drug alemtuzumab reduced relapse rates by half, researchers say.

Alemtuzumab Reverses Disability in Some

Alemtuzumab has been used to treat MS for close to two decades, but it has never been approved for this use. It is given by IV infusion.

The drug not only reduced relapses, but improved disability associated with MS, such as loss of coordination or difficulty walking, in some patients.

Side effects include infusion reactions, infections, and potentially serious autoimmune disorders. Patients taking it must be followed closely.

“In the menu of treatment choices for MS patients, I think alemtuzumab falls into the ‘high-reward, high-risk’ category,” says Alasdair Coles, MD, of Britain’s University of Cambridge, who led one of the newly published studies.

“No other drug has been shown to offer the benefits in terms of disability improvement that this drug shows,” he says. "It comes with problems, but these problems are manageable.”... Read More - http://www.msrc.co.uk/index.cfm/fuseact ... ageid/1307

_________________
The Multiple Sclerosis Resource Centre

Squiffy's House of Fun - Laughter for Multiple Sclerosis


Top
 Profile  
 
PostPosted: Thu Nov 01, 2012 4:18 am 
Offline
Family Elder
User avatar

Joined: Wed Jul 27, 2005 3:00 pm
Posts: 2735
Location: Sydney, Australia
I am confused. On the same page linked above, are the quotes
Quote:
Lemtrada, also known as alemtuzumab, is a so-called monoclonal antibody administered to patients through infusions for five consecutive days when they begin the treatment and for another three days 12 months later.

But on the same page, we have the heading.
Quote:
FDA refuses oral MS drug Lemtrada filing

I would guess its some kind of typo.


Top
 Profile  
 
PostPosted: Thu Nov 01, 2012 4:27 am 
Offline
Family Elder
User avatar

Joined: Wed Oct 14, 2009 3:00 pm
Posts: 1711
Yep typo....................opps! *my bad*

Corrected, thanks :-D

_________________
The Multiple Sclerosis Resource Centre

Squiffy's House of Fun - Laughter for Multiple Sclerosis


Top
 Profile  
 
PostPosted: Mon Mar 11, 2013 10:45 am 
Offline
Newbie

Joined: Mon Mar 11, 2013 10:10 am
Posts: 1
I'm tired of dinking around with Interferons and Copaxone, but am still highly functional, but getting worse... vision is starting to get seriously whacked, the pain is becoming unbearable, etc... so, the neurologists that I have seen are like "let's wait till you have a major disability, then we'll look at more serious options".... I'm also JC+ so Tysabri is really out...

SO.... I need a referral to a neurologist (anywhere in the world... I'm in US, but am willing to travel and pay out of pocket) who will give me Campath. Any referrals?


Top
 Profile  
 
Display posts from previous:  Sort by  
Post new topic Reply to topic  [ 4 posts ] 

All times are UTC - 8 hours [ DST ]


Related topics
 Topics   Author   Replies   Views   Last post 
There are no new unread posts for this topic. Lemtrada (alemtuzumab) improved disability scores in MS pts

squiffy2

0

1251

Wed Apr 25, 2012 2:25 am

squiffy2 View the latest post

There are no new unread posts for this topic. Spotlight on Alemtuzumab

Waterbear

2

2007

Mon Mar 08, 2010 5:57 pm

leetz View the latest post

There are no new unread posts for this topic. Autoimmune disease after alemtuzumab treatment for MS

squiffy2

0

1391

Wed Sep 14, 2011 3:42 am

squiffy2 View the latest post

There are no new unread posts for this topic. Alemtuzumab more effective than interferon β-1a at 5-years

squiffy2

0

990

Wed Mar 28, 2012 12:33 am

squiffy2 View the latest post

There are no new unread posts for this topic. Approval sought for Lemtrada(TM) (alemtuzumab) for MS

squiffy2

0

789

Tue Jun 12, 2012 2:09 am

squiffy2 View the latest post

 


Who is online

Users browsing this forum: No registered users


You cannot post new topics in this forum
You cannot reply to topics in this forum
You cannot edit your posts in this forum
You cannot delete your posts in this forum

Search for:
Jump to:  


News News Site map Site map SitemapIndex SitemapIndex RSS Feed RSS Feed Channel list Channel list
Read hundreds of personal Multiple Sclerosis stories on Experience Project. Experience Project is an anonymous community where people connect through their life experiences, made by the same people who built This is MS. With over 30 million personal stories about every possible life experience, you can quickly find people like you!


Interesting: Secret Confessions | Dream Meanings | Ask Questions, Get Answers

Advertise on the premier multiple sclerosis forum